PlainRecalls
FDA Drug Moderate Class II Terminated

Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI Pharmaceuticals, Inc. Ridgefield, CT 06877 and Eli Lilly and Company Indianapolis IN 46285 NDC 0597-0175-18

Reported: October 3, 2018 Initiated: September 4, 2018 #D-1217-2018

Product Description

Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI Pharmaceuticals, Inc. Ridgefield, CT 06877 and Eli Lilly and Company Indianapolis IN 46285 NDC 0597-0175-18

Reason for Recall

Cross Contamination With Other Products:

Details

Units Affected
998 180-count bottles
Distribution
Nationwide
Location
Ridgefield, CT

Frequently Asked Questions

What product was recalled?
Synjardy (empagliflozin and metformin hydrochloride) Tablets. 5 mg/1000 mg. Rx only. 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877. Made in Germany. Marketed by: BI Pharmaceuticals, Inc. Ridgefield, CT 06877 and Eli Lilly and Company Indianapolis IN 46285 NDC 0597-0175-18. Recalled by Boehringer Ingelheim Pharmaceuticals, Inc.. Units affected: 998 180-count bottles.
Why was this product recalled?
Cross Contamination With Other Products:
Which agency issued this recall?
This recall was issued by the FDA Drug on October 3, 2018. Severity: Moderate. Recall number: D-1217-2018.